Lumexa Imaging Holdings, Inc. (LMRI)
| Market Cap | 1.10B |
| Revenue (ttm) | 1.04B +10.0% |
| Net Income | -27.73M |
| EPS | -0.33 |
| Shares Out | 96.07M |
| PE Ratio | n/a |
| Forward PE | 14.53 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 244,486 |
| Open | 11.80 |
| Previous Close | 11.73 |
| Day's Range | 11.26 - 11.88 |
| 52-Week Range | 6.45 - 19.45 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 17.67 (+54.86%) |
| Earnings Date | Nov 10, 2026 |
About LMRI
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
Financial Performance
In 2025, Lumexa Imaging Holdings's revenue was $1.02 billion, an increase of 7.82% compared to the previous year's $948.87 million. Losses were -$47.10 million, -49.94% less than in 2024.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for LMRI stock is "Strong Buy." The 12-month stock price target is $17.67, which is an increase of 54.86% from the latest price.
News
Lumexa Imaging Announces Third Quarter 2026 Earnings Conference Call Date
RALEIGH, N.C., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its third quarter ...
Lumexa Imaging initiated with a Buy at Truist
Truist initiated coverage of Lumexa Imaging (LMRI) with a Buy rating and $18 price target The firm says the diagnostic imaging market is “large, growing and fragmented with plenty of…
Lumexa Imaging initiated with an Overweight at KeyBanc
KeyBanc analyst Matthew Gillmor last night initiated coverage of Lumexa Imaging (LMRI) with an Overweight rating and $18 price target The firm views diagnostic imaging as an attractive subsector in…
Lumexa Imaging initiated with an Overweight at KeyBanc
KeyBanc analyst Matthew Gillmor initiated coverage of Lumexa Imaging (LMRI) with an Overweight rating and $18 price target
Lumexa Imaging Holdings Transcript: Wells Fargo 21st Annual Healthcare Conference
A leading outpatient imaging provider is accelerating growth through de novo expansion, joint ventures with health systems, and a focus on advanced imaging, supported by operational and AI-driven efficiencies. Recent policy trends and resumed M&A activity are expected to further enhance long-term growth and margin expansion.
Lumexa Imaging price target raised to $13 from $9 at Barclays
Barclays raised the firm’s price target on Lumexa Imaging (LMRI) to $13 from $9 and keeps an Overweight rating on the shares. The firm updated models in the healthcare facilities…
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, announced today ...
Lumexa Imaging price target lowered to $16 from $22 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Lumexa Imaging (LMRI) to $16 from $22 and keeps a Buy rating on the shares.
Lumexa Imaging Holdings Earnings Call Transcript: Q2 2026
Q2 saw strong revenue and volume growth, with advanced modalities reaching a record 37.4% of volume and PET volumes up 23.2%. Guidance was reaffirmed, free cash flow hit a record, and new partnerships and technology initiatives are driving expansion.
Lumexa Imaging Holdings Earnings release: Q2 2026
Lumexa Imaging Holdings released its Q2 2026 earnings on August 12, 2026, summarizing the period's financial results.
Lumexa Imaging Holdings Quarterly report: Q2 2026
Lumexa Imaging Holdings has published its Q2 2026 quarterly earnings report on August 12, 2026.
Lumexa Imaging Holdings Slides: Q2 2026
Lumexa Imaging Holdings has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 12, 2026.
Lumexa Imaging Announces Second Quarter 2026 Results
RALEIGH, N.C., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today reported results for the second quarter ende...
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
RALEIGH, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its second quarter...
Lumexa Imaging forms strategic joint venture with Hospital for Special Surgery
Lumexa Imaging (LMRI) announced the formation of a strategic joint venture with Hospital for Special Surgery. The collaboration represents Lumexa Imaging’s ninth joint venture. Lumexa Imaging and HSS ...
Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York
RALEIGH, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced the formation of a strategic joint...
Lumexa Imaging price target lowered to $9 from $15 at Barclays
Barclays lowered the firm’s price target on Lumexa Imaging (LMRI) to $9 from $15 and keeps an Overweight rating on the shares. The firm says RadNet is outperforming Lumexa on…
Lumexa Imaging director buys 30K shares of common stock
In a regulatory filing, Lumexa Imaging (LMRI) disclosed that its director, Henry Cooper, bought 30K shares of common stock on May 14th in a total transaction size of $223K. Shares…
Lumexa Imaging Holdings Earnings Call Transcript: Q1 2026
Q1 revenue grew 3% year-over-year to $253 million, with advanced modalities driving 7% volume growth and PET up 23%. Adjusted EBITDA was flat at $51.2 million, impacted by weather and seasonality, but guidance for 2026 remains strong with expected ramp in the second half.
Lumexa Imaging Holdings Earnings release: Q1 2026
Lumexa Imaging Holdings released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.
Lumexa Imaging Holdings Quarterly report: Q1 2026
Lumexa Imaging Holdings has published its Q1 2026 quarterly earnings report on May 12, 2026.
Lumexa Imaging Announces First Quarter 2026 Results
RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended...
Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers
RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced the addition of four new locations ...
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced it will release its first quarter...
Lumexa Imaging Holdings Proxy statement: Proxy filing
Lumexa Imaging Holdings filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.